Dividend investors would be wise to focus not just on a stock's current yield, but also on the long-term growth potential of its dividends. That's because strong businesses that consistently raise their dividend payouts reward shareholders with a steadily rising income stream that essentially equates to a raise every year. And well, who doesn't like a raise?
But there are other reasons to value dividend growth so highly, and they're well supported by research. For instance, a study by C. Thomas Howard published in Advisor Perspectives found that for every percentage point a stock's yield rises, its annual return increases by 0.22 percentage points if it's a large cap, 0.25 if it's a midcap, and 0.46 if it's a small cap. Even better, Howard found that dividend-growing stocks outperformed dividend cutters by 10 percentage points per year from 1973 to 2010 and beat both flat- and no-dividend stocks. And the icing on the cake is that Howard showed that this outperformance came with a third less volatility. Higher returns, less volatility-induced stress, and a steadily growing income stream -- what's not to love?
Hot Shipping Stocks To Buy For 2015: NPS Pharmaceuticals Inc.(NPSP)
NPS Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic products for gastrointestinal and endocrine disorders, and various medical needs. The company?s primary clinical programs include two therapeutic peptides to restore or replace biological functions comprising GATTEX, a Phase 3 clinical trial product for short bowel syndrome; and Natpara, a recombinant human parathyroid hormone 1-84, which is in Phase 3 clinical development trials. It also develops NPSP790 and NPSP795 calcilytic compounds that are in Phase I trials for the treatment of rare endocrine disorders. The company has collaborative and license agreements with Amgen Inc., Janssen, GlaxoSmithKline, Kyowa Hakko Kirin, and Nycomed Danmark ApS. NPS Pharmaceuticals, Inc. was founded in 1986 and is based in Bedminster, New Jersey.
Advisors' Opinion:- [By Keith Speights]
Two high-flying biotech stocks of late are NPS Pharmaceuticals (NASDAQ: NPSP ) and Regeneron Pharmaceuticals (NASDAQ: REGN ) . Both have had great results over the past month.
- [By Ben Levisohn]
Markey rates the stock a Buy with an $11 price target. Shares of MannKind have jumped 14% to $7.85 today. The SPDR Biotech ETF (XBI) has gained 0.7% to $119.85 today, while Alnylam Pharmaceuticals (ALNY) has gained 1% to $49.05, NPS Pharmaceuticals (NPSP) has fallen 4.1% to $23.56, and InterMune (ITMN) has risen 2.6% to $14.89.
- [By Jesse Solomon]
NPS Pharmaceuticals (NPSP), for example, created a drug for treating short bowel syndrome. And Hyperion Therapeutics (HPTX) is developing a drug for hepatic encephalopathy, a decline of brain function that according to the National Institute of Health occurs when the liver is no longer able to remove toxins from the blood. Those stocks are up 20% and 40%, respectively, this year.
Best Heal Care Companies To Own For 2014: U.S. Energy Corp.(USEG)
U.S. Energy Corp. engages in the acquisition, exploration, holding, sale, and/or development of mineral properties. It primarily explores for molybdenum, and other base and precious metals. The company holds interests in Mount Emmons property that covers approximately 9,311 acres located in Gunnison County, Colorado. It also holds interests in oil and gas properties located in Williston Basin North Dakota and Gulf Coast region. In addition, the company holds interests in geothermal properties. Further, it develops multifamily apartment project in Gillette, Wyoming. As of December 31, 2009, its estimated proved reserves were approximately 1,086,203 BOE. The company was founded in 1966 and is based in Riverton, Wyoming.
Advisors' Opinion:- [By Roberto Pedone]
US Energy (USEG), an independent energy company, focuses on the acquisition and development of oil and gas producing properties in the continental U.S. This stock closed up 6.9% to $3.53 in Thursday's trading session.
Thursday's Range: $3.29-$3.53
52-Week Range: $1.45-$4.06
Thursday's Volume: 116,000
Three-Month Average Volume: 219,710From a technical perspective, USEG bounced sharply higher here right off some near-term support at $3.27 and back above its 50-day moving average of $3.45 with lighter-than-average volume. This stock recently formed a triple bottom chart pattern at $3.32, $3.21 and $3.27. Since finding buying interest at those levels, shares of USEG are now spiking higher and moving within range of triggering a near-term breakout trade. That trade will hit if USEG manages to take out some near-term overhead resistance levels at $3.65 to $3.80 with high volume.
Traders should now look for long-biased trades in USEG as long as it's trending above some key near-term support levels at $3.27 or at $3.21 and then once it sustains a move or close above those breakout levels with volume that hits near or above 219,710 shares. If that breakout hits soon, then USEG will set up to re-test or possibly take out its 52-week high at $4.06. Any high-volume move above that level will then give USEG a chance to tag its next major overhead resistance levels at $4.60 to $5.
Best Heal Care Companies To Own For 2014: Medizone International Inc (MZEI)
Medizone International, Inc. (Medizone), incorporated in January 31, 1986, is a development-stage company. The Company is engaged in research into the medical uses of ozone. Medizone focuses in the field of hospital sterilization. It is a research and development company engaged in developing its AsepticSure. The Company is developing an ozone-based technology (AsepticSure) for decontaminating and sterilizing hospital surgical suites, emergency rooms, and intensive care units.
The Company started hospital beta-testing of a prototype system utilizing the original technology. The first round of in-hospital beta-testing for this AsepticSure hospital disinfection system was completed at a Hotel Dieu hospital in Kingston, Ontario, Canada. In addition to the hospital disinfection system, it employs an ozone-destruct unit which is used following disinfection of the treated infrastructure to reverse the O3 gas in the space, and turn it back into O2 in a short period of time. The Company�� subsidiaries include Medizone Canada, Ltd. (MedCan). As of December 31, 2011, the Company had not generated any revenues.
Advisors' Opinion:- [By CRWE]
Today, MZEI surged (+5.64%) up +0.0048 at $.0899 with 21,900 shares in play thus far (ref. google finance Delayed: 1:32PM EDT October 16, 2013).
Medizone International, Inc. previously reported that its WHO award-winning green infection control technology, AsepticSure has been Granted a patent by the United States Patent and Trademark office. (US 61/223,219) titled “Healthcare Facility Disinfecting System”. The AsepticSure infection control system has repeatedly demonstrated 100% microbial kill rates when used to decontaminate hospital rooms of the causative agents of HAI (hospital acquired infections).
“With patent protection now established in the United States, Canada and Singapore and pending applications in process for the 37 member countries of the EU as well as Korea, Japan, China, India, Brazil and Mexico, our patent momentum is clearly gaining strength,” stated Edwin Marshall, Medizone’s CEO.
Best Heal Care Companies To Own For 2014: Cypress Semiconductor Corporation (CY)
Cypress Semiconductor Corporation designs, develops, manufactures, and markets mixed-signal programmable solutions, specialized semiconductor memories, and integrated semiconductor solutions. The company�s Memory Products division designs and manufactures static random access memory (SRAM) products and nonvolatile SRAMs used to store and retrieve data in networking, wireless infrastructure and handsets, computation, consumer, automotive, industrial, and other electronic systems, as well as offers general-purpose programmable clocks. Its Data Communications division focuses on universal serial bus (USB) controllers, WirelessUSB peripheral controllers, and module based solutions for trackpads and other user interface applications used in PC and peripheral, industrial automation imaging, security camera, and in consumer devices, such as mobile handsets and set-top boxes. The company�s Programmable Solutions division designs and develops programmable product offerings, inclu ding Programmable System-on-Chip (PSoC) devices, as well as CapSense and TrueTouch touch-sensing/touch screen products; and automotive products. This segment�s PSoC products are used in various industrial applications, mass storage, household appliances, laptop computers, and toys; TrueTouch touch screen products are used in mobile phones, tablets, e-readers, GPS, automobiles, digital cameras, and other mobile systems; and CapSense devices are used in various applications that employ buttons or sliders, including handsets and various other consumer, industrial, and automotive applications. Its Emerging Technology division provides foundry services, as well as other development stage activities. The company sells its semiconductor products through distributors, manufacturing representative firms, and its sales force to direct original equipment manufacturers and their manufacturers worldwide. Cypress Semiconductor Corporation founded in 1982 and is headquartered in San Jose, California.
Advisors' Opinion:- [By Evan Niu, CFA]
What: Shares of Cypress Semiconductor (NASDAQ: CY ) have popped today by upwards of 11% after the company reported better-than-expected earnings.
- [By Luke Jacobi]
Cypress Semiconductor (NASDAQ: CY) traded down 14.87 percent to $9.65 after the company lowered its Q3 forecast.
Red Hat (NYSE: RHT) shares tumbled 11.71 percent to $46.73 after the company reported Q2 results. Piper Jaffray downgraded the stock from Overweight to Neutral.
- [By Jake L'Ecuyer]
EZchip Semiconductor (NASDAQ: EZCH) was also up, gaining 7.16 percent to $24.11 after a Cisco (NASDAQ: CSCO) announced a new product that would not threaten the company as previously thought. Equities Trading DOWN
Shares of Cypress Semiconductor (NASDAQ: CY) were down 16.05 percent to $9.91 after the company lowered its Q3 forecast.
Best Heal Care Companies To Own For 2014: Peoples Bancorp of North Carolina Inc.(PEBK)
Peoples Bancorp of North Carolina, Inc. operates as the holding company for Peoples Bank, which provides various banking products and services to individuals and small to medium-sized businesses in Catawba Valley and surrounding communities in North Carolina. Its deposit products include demand deposits; interest-bearing checking accounts; NOW, MMDA, and savings deposits; regular savings accounts; money market accounts; time deposits; and certificates of deposit. The company?s lending portfolio comprises commercial loans, real estate mortgage loans, real estate construction loans, and consumer loans, as well as agricultural loans. It also provides real estate appraisal and real estate brokerage services, as well as access to investment counseling and non-deposit investment products, such as stocks, bonds, mutual funds, tax deferred annuities, and related brokerage services. It operates 22 banking offices located in Lincolnton, Newton, Denver, Catawba, Conover, Maiden, Cla remont, Hiddenite, Hickory, Charlotte, Monroe, Cornelius, Mooresville, and Raleigh in North Carolina, as well as a loan production office in Denver, North Carolina. The company was founded in 1912 and is based in Newton, North Carolina.
Advisors' Opinion:- [By Tim Melvin]
Peoples Bank of North Carolina (PEBK) has also seen strong insider buying recently. One director as well as the CEO and Chairman of the board have made open market purchases of the stock in the past few months. The bank serves the central areas of North Carolina and also operates Banco de la Gente, which has four branches that serve the region�� fast-growing Latin American community. The bank serves a market with above-average economic prospects and has a very attractive 22-branch network that is likely to attract the attention of larger banks in the region.
Best Heal Care Companies To Own For 2014: Alliance Capital Management Holding L.P. (AB)
AllianceBernstein Holding L.P. provides investment management and related services in the United States and internationally. It offers institutional services, including separately-managed accounts, sub-advisory relationships, structured products, collective investment trusts, mutual funds, hedge funds, and other investment vehicles to unaffiliated corporate and public employee pension funds, endowment funds, domestic and foreign institutions, and governments. The company also provides retail services comprising retail mutual funds, sub-advisory relationships with mutual funds sponsored by third parties, and separately managed account programs sponsored by various financial intermediaries and other investment vehicles. In addition, it provides separately managed accounts, hedge funds, mutual funds, and other investment vehicles for private clients, including high-net-worth individuals, trusts and estates, charitable foundations, partnerships, and private and family corporat ions. Further, AllianceBernstein Holding L.P. offers research services to institutional investors through research, portfolio analysis, and brokerage-related services; and equity capital markets services to issuers of publicly-traded securities. Additionally, it provides distribution, shareholder servicing, and administrative services to its sponsored mutual funds. AllianceBernstein Corporation serves as the general partner of the company. AllianceBernstein Holding L.P. was founded in 1987 and is based in New York, New York. AllianceBernstein Holding L.P. operates as a subsidiary of AXA.
Advisors' Opinion:- [By Dan Caplinger]
In the following video, Dan Caplinger, The Motley Fool's director of investment planning, goes through a few situations where an IRA rollover might not be ideal. Dan notes that Franklin Templeton (NYSE: BEN ) , AllianceBernstein (NYSE: AB ) , Goldman Sachs (NYSE: GS ) , and other companies often offer cheaper class of mutual funds that would otherwise carry sales loads or higher fees outside a 401(k). Dan also talks about company stock and the special rules for 401(k)s that own it, as well as the importance of looking at overall fees to decide if your 401(k) is the best place to invest or whether an IRA rollover will help you more.
No comments:
Post a Comment